2020
DOI: 10.1109/tcst.2018.2849068
|View full text |Cite
|
Sign up to set email alerts
|

Experimental Modeling and Identification of Cardiac Biomarkers Release in Acute Myocardial Infarction

Abstract: Cardiovascular diseases represent, to date, the major cause of mortality worldwide. Diagnosis of the most frequent of such disease, Acute Myocardial Infarction (AMI), requires the evaluation of time-series measurement of specific cardiac biomarkers concentration. The aim of this work is to provide the clinicians with a quantitative tool to analyze such time-series, with the final goal of enhancing the diagnostic and prognostic procedures. The proposed approach is based on a novel dynamical model, which synthet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
3

Relationship

4
5

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…Mathematical modeling applied to drug delivery and its release represents a new and promising scientific field, from which medicine [144,145], the pharmaceutical industry, and research [146], can greatly benefit. Taking advantage of the vast knowledge on well-known physical processes, such as diffusion, degradation, a model appropriately designed and correctly defined from a mathematical point of view can, in short time and with relatively low costs, bring improvements in the design of new [143] therapeutic plans that optimize the administered dose, improving the results of the treatment.…”
Section: In Silico Modelsmentioning
confidence: 99%
“…Mathematical modeling applied to drug delivery and its release represents a new and promising scientific field, from which medicine [144,145], the pharmaceutical industry, and research [146], can greatly benefit. Taking advantage of the vast knowledge on well-known physical processes, such as diffusion, degradation, a model appropriately designed and correctly defined from a mathematical point of view can, in short time and with relatively low costs, bring improvements in the design of new [143] therapeutic plans that optimize the administered dose, improving the results of the treatment.…”
Section: In Silico Modelsmentioning
confidence: 99%
“…Based on the abovementioned dynamics of an AMI, a three-compartmental model composed of three ordinary differential equations describing the variation in the concentration of the cardiac troponin T, cTnT, in sarcomere (C s ), cytosol (C c ), and plasma (C p ), was defined, [29][30][31], as follows:…”
Section: Nonlinear Model Of Cardiac Troponin T (Ctnt) Release In Ami ...mentioning
confidence: 99%
“…Finally, examples at the macro-scale level are the control systems for the regulation of cardiovascular processes, neuromuscular activities, respiration dynamics, etc. [7,[24][25][26][27][28][29][30][31]. This category of systems incorporates a negative feedback control scheme, within a closed-loop configuration, which permits the values of the physiological parameters to be kept near to the equilibrium itself in order to preserve the homeostatic equilibrium [7,32].…”
Section: Introductionmentioning
confidence: 99%